Short CV

Download one-page CV

Professional appointments

  • Professor in general practice in general practice with main focus on addiction research and clinical epidemiology at Heinrich-Heine University Düsseldorf (D), with honorary appointments at:
  • Maastricht University (NL)
  • University College London (UK)
  • University of Edinburgh (UK)

Training and education (selection)

  • PhD degree, Maastricht University, 2008
  • Master’s degree Epidemiology (cum laude), Maastricht University, 2006
  • Master’s degree Health Sciences, Maastricht University, 2003
  • Diploma Physiotherapy, University of Professional Education Arnhem and Nijmegen, 2000

Management positions and memberships (selection)

  • Head, Addiction Research and Clinical Epidemiology unit, 2015-present (
  • Board member and (Past-)President, Society for Research on Nicotine and Tobacco Europe, 2018-2020 (
  • Co-founder and member of the steering committee, Netherlands Network of Tobacco Research, 2013-present (
  • Member, International Primary Care Research Leadership Programme, 2008-present  (

Main research interests

  • Tobacco addiction: effectiveness of behavioural and pharmacological treatments
  • Chronic obstructive pulmonary disease (COPD): prediction modelling, early detection, prevention
  • Clinical epidemiology: research methodology and reporting

Current major funding programs

  • German Federal Ministry of Health (BMG): “German Study on Tobacco Use (DEBRA-II)” (PI: €422,064)
  • German Federal Ministry of Education and Research (BMBF): “NRW General Practice Research Network” (Co-PI: €3,750,000)
  • EU Horizon 2020: “Tobacco cessation within TB programmes” (Co-PI: €2,999,829)
  • German Federal Ministry of Health (BMG): “Training general practitioners in brief stop-smoking advice” (PI: €399,804)
  • NRW Ministry for Innovation, Science and Research: “Treating tobacco addiction: new clinical approaches” (PI: €1,250,000)

Contributions to scientific meetings (selection)

  • Keynote lecture: Society for Research on Nicotine and Tobacco (SRNT) Europe, online, 17-09-2020
  • Scientific program committee chair: Society for Research on Nicotine and Tobacco (SRNT) Europe, Munich (D), 06-09-2018
  • Scientific program committee: German Society for General Practice and Family Medicine (DEGAM). Düsseldorf (D): 21-09-2017
  • Conference co-chair: Society for Research on Nicotine and Tobacco (SRNT), Florence (IT), 08-03-2017

Editorial work and review

  • Senior Editor of Addiction, 2013-present (
  • Associate Editor of the Journal of Clinical Epidemiology, 2009-2017, Editorial Board member 2018-present (
  • Expert reviewer for 48 different journals (incl. Ann Intern Med, BMJ,  ERJ, Lancet ) and 12 different funding agencies

Awards (selection)

  • Lothar Beyer Research Award of the German Foundation of General Practice and Family Medicine (3rd prize), 2019
  • Pharmacoepidemiology and Drug Safety Best Reviewer Award, 2013
  • Netherlands School for Primary Care Research Lecturer of the Year Award, 2010
  • European Respiratory Society Young Scientist Sponsorship, 2008

Key publications

  1. Dogar O, Keding A, […] Kotz D et al. Cytisine for smoking cessation in patients with tuberculosis: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial. The Lancet Global Health. 2020;8(11):e1408-e1417.
  2. Kotz D, Böckmann M, Kastaun S. The use of tobacco, e-cigarettes, and methods to quit smoking in Germany—a representative study using 6 waves of data over 12 months (the DEBRA study). Dtsch Arztebl Int 2018; 115:235-242
  3. van Rossem C, […] Kotz D. Effectiveness of intensive practice nurse counselling versus brief general practitioner advice, both combined with varenicline, for smoking cessation. Addiction 2017; 112:2237-2247
  4. Kotz D, Viechtbauer W, Simpson C, et al. Cardiovascular and Neuropsychiatric Risks of Varenicline: a retrospective cohort study using a national general practice database The Lancet Respiratory Medicine; 2015;3(10):761-768.
  5. Brown J, Beard E, Kotz D, et al. Real-world effectiveness of e-cigarettes when used to aid smoking cessation: a cross-sectional population study. Addiction 2014; 109:1531-1540
  6. Kotz D, Wesseling GJ, Huibers MJH, van Schayck CP. Efficacy of confronting smokers with airflow limitation for smoking cessation. Eur Respir J 2009; 33:754-762
  7. Kotz D, West R. Explaining the social gradient in smoking cessation: it’s not in the trying but in the succeeding. Tob Control 2009; 18: 43-46


My tweets @daniel_kotz

%d bloggers like this: